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Abstract
Background: Hexavalent chromium [Cr(VI)] is a potent human carcinogen. Occupational exposure has been associated with
increased risk of respiratory cancer. Multiple mechanisms have been shown to contribute to Cr(VI) induced carcinogenesis,
including DNA damage, genomic instability, and epigenetic modulation, however, the molecular mechanism and
downstream genes mediating chromium’s carcinogenicity remain to be elucidated.
Methods/Results: We established chromate transformed cell lines by chronic exposure of normal human bronchial
epithelial BEAS-2B cells to low doses of Cr(VI) followed by anchorage-independent growth. These transformed cell lines not
only exhibited consistent morphological changes but also acquired altered and distinct gene expression patterns compared
with normal BEAS-2B cells and control cell lines (untreated) that arose spontaneously in soft agar. Interestingly, the gene
expression profiles of six Cr(VI) transformed cell lines were remarkably similar to each other yet differed significantly from
that of either control cell lines or normal BEAS-2B cells. A total of 409 differentially expressed genes were identified in Cr(VI)
transformed cells compared to control cells. Genes related to cell-to-cell junction were upregulated in all Cr(VI) transformed
cells, while genes associated with the interaction between cells and their extracellular matrices were down-regulated.
Additionally, expression of genes involved in cell proliferation and apoptosis were also changed.
Conclusion: This study is the first to report gene expression profiling of Cr(VI) transformed cells. The gene expression
changes across individual chromate exposed clones were remarkably similar to each other but differed significantly from
the gene expression found in anchorage-independent clones that arose spontaneously. Our analysis identified many novel
gene expression changes that may contribute to chromate induced cell transformation, and collectively this type of
information will provide a better understanding of the mechanism underlying chromate carcinogenicity.
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Introduction
Hexavalent chromium [Cr(VI)] is widely used in numerous
industrial processes, including chrome pigment production,
chrome plating, stainless steel manufacturing, and leather tanning,
etc. Epidemiological studies have reported a high incidence of lung
cancer among chromium workers exposed occupationally to
Cr(VI) by inhalation [1–3]. An early epidemiology study showed
that 21.8% of deaths among chromium workers were due to
respiratory cancer while only 1.4% of deaths could be attributed to
respiratory cancer in the unexposed reference population [2]. The
lung cancer risk among chromium workers was positively
correlated with a longer duration of employment and with
exposure to less water-soluble chromate compounds [2]. Numer-
ous studies suggested that chromate induced DNA damage,
mutation, genetic instability and epigenetic modulation of histones
and DNA may contribute to its carcinogenicity, however, the
molecular mechanisms of Cr(VI) induced lung cancer are not well
understood.
Chromate can induce a wide variety of injuries in cells. After
entering cells, Cr(VI) undergoes a series of metabolic reductions to
form reactive Cr(V) and Cr(IV) intermediates as well as the final
stable metabolite Cr(III) [4][5]. These reactive intermediates and
final products generated from the reduction process are able to
induce the formation of stable Cr-DNA ternary adducts, protein-
DNA cross-links, and DNA-DNA cross-links. These modifications,
in combination with reactive oxygen species (ROS), may generate
DNA single or double-strand breaks, which in turn may lead to
mutations, chromosomal aberrations, and microsatellite instability
[6][7]. An increased frequency of microsatellite instability in
Cr(VI)-induced lung tumors has been attributed to the ability of
chromate to disrupt DNA mismatch repair [8][9].
In addition to DNA damage, Cr(VI) is able to induce a broad
range of changes in the epigenetic machinery. Chromium
exposure of G12 Chinese hamster cells increased both genome-
wide and gene-specific DNA methylation and silenced the
expression of a gpt transgene [10]. In human lung cells, chromium
exposure modulated histone methylation in both global and gene
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dimethylation, a silencing mark, was enriched in the human DNA
mismatch repair MLH1 gene promoter following chromate
exposure and this was correlated with decreased MLH1 mRNA
expression [11]. Moreover, increased DNA methylation in the
promoter region of MLH1 gene and subsequent gene silencing
were found in chromium-induced human lung tumors [8],
suggesting epigenetic modulation as an important mechanism
mediating Cr(VI)-induced lung carcinogenesis.
Cr(VI) induced tumorigenesis is thought to be a multistep
process involving DNA damage, mutation, chromosome instabi-
lilty, aneuploidy, as well as epigenetic modulation [3]. The
ultimate outcome of this process is the malignant cell phenotype
that exhibited an altered gene expression profile. Previous studies
have shown changes in gene expression following acute exposure
of human cells to chromate (1 day or less), and identified a number
of genes that were altered in response to acute chromate induced
stress [12–14]. However, due to the complex effects of chromate in
cells, changes noted in these early response genes may not play a
role in cell transformation and tumorigenesis that arises with a
latency period of at least a month. The purpose of our study was to
identify genes that are characteristic of Cr(VI) induced cell
transformation. Here, we employed a strategy to select cells for
anchorage-independent growth following chronic chromate expo-
sure. Our results showed that chronic exposure of immortalized
normal human bronchial epithelial BEAS-2B cells to low doses of
chromate promoted a high incidence of anchorage-independent
growth. Interestingly, cell lines derived from soft agar colonies
following chromate exposure exhibited altered morphology
compared to cell lines derived from the untreated small colonies
that arose spontaneously which morphologically resembled
normal BEAS-2B cells. 409 differentially expressed genes were
identified in Cr(VI) transformed cells compared to control cells,
and these changes contributed to the functional and phenotypic
differences between these two cell populations. It is of interest that
gene expression profiles in six independent cell lines derived from
Cr(VI) treated cells were very similar to each other, yet differed
greatly from gene expression profiles in control cell lines derived
from colonies that arose spontaneously in soft agar.
Results
Establishment of chromate transformed cell lines
With the exception of cells from hematopoietic and lymphoid
lineages, most normal cells rely on physical attachment to the
extracellular matrix in order to manifest normal cell growth. In
contrast, many transformed cells acquire the ability to grow and
survive without attaching themselves to the substratum, a
phenomenon commonly known as anchorage-independent
growth. Due to its high correlation with tumor progression in vivo,
anchorage independent growth has been considered a hallmark of
cell malignancy and is used as a marker for in vitro cell
transformation assays [15][16]. In order to establish Cr(VI)
transformed cell lines, we employed a strategy to select and sub-
clone the transformed cells by taking advantage of their ability to
grow in an anchorage-independent manner (Figure 1A).
To mimic low dose and long term exposure in vivo, immortalized
human bronchial epithelial BEAS-2B cells were continuously
cultured in medium containing 0.25 or 0.5 mM of Cr(VI), doses in
which BEAS-2B cells exhibited minimal toxicity (Figure 1B).
Figure 1. Effect of Cr(VI) on colony survival of immortalized human bronchial epithelial BEAS-2B cells. (A) Schematic presentation of
the strategy to establish Cr(VI) transformed cell lines. (B) BEAS-2B cells were exposed to different doses of Cr(VI) (0.25, 0.5, 1.0, 2.0, and 4.0 mM) for
24 hours, and then subjected to colony survival assay in the absence of Cr(VI) for 2 weeks. Cell colonies were stained with Giemsa solution. The
number of colonies was counted and presented as the mean 6 SD (n=3).
doi:10.1371/journal.pone.0017982.g001
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state. While Cr(VI) treated cells exhibited a slower growth rate
compared to untreated cells, no obvious difference in cell
morphology was observed during the treatment (data not shown).
After a 4-week exposure, anchorage-independent growth was
assessed in both untreated and chromate treated BEAS-2B cells.
Both Cr(VI) treated and untreated control BEAS-2B cells were
grown in 0.35% top agar for three weeks. While there was a low
level of background growth with untreated BEAS-2B cells, both
0.25 and 0.5 mM Cr(VI) treated cells formed significantly more
colonies in soft agar (Figure 2A). Cells exposed to Cr(VI)
demonstrated the greatest number of colonies that were three times
moreabundant compared to theuntreated cells (Figure2B). These
results indicated that Cr(VI) exposure was able to significantly
enhance anchorage-independent growth of BEAS-2B cells.
After 3 weeks of growth in soft agar, colonies reached a size that
allowed them to be collected individually using a dissecting
microscope. Five colonies were isolated from untreated colonies
that arose spontaneously in soft agar and this group was
designated as the control group. Ten colonies were selected from
the 0.5 mM Cr(VI) exposure for further study. Five of these were
large colonies and therefore designated as the Cr_large group,
while the other five were selected to best match the size of the
untreated control colonies and designated as Cr_small group.
Isolated colonies were trypsinized and expanded in monolayer
culture. Thus, each sub-cloned cell line contained a cell population
derived from a single cell.
After expansion in monolayer culture, Cr(VI) transformed cells
exhibited distinct cell morphology compared to control cells. As
shown in Figure 3A, control cells were flat, diamond-shaped, and
similar to their parental BEAS-2B cells, while cells in both the
Cr_large and the Cr_small groups were rounder, forming a more
compact ‘‘cobblestone’’ monolayer. In addition, these Cr(VI)
transformed cells easily detached from the culture surface when
trypsinized, and exhibited a slightly faster growth rate as compared
to control cells (Figure 3B). Moreover, 9 out of 12 mice injected
with cells from Cr_large and Cr_small group developed tumors,
while the mice injected with control cells did not form tumors after
6 months (Figure 3C). These data indicated that chronic
exposure to Cr(VI) resulted in malignant transformation of
BEAS-2B cells.
Differential gene expression profiles in control and Cr(VI)
transformed cells
Cr(VI) induced cell transformation is a multistep process in
which cells go through an initial adaption to Cr(VI)-induced cell
death and toxicity, then displayed anchorage-independent growth,
and with time acquired the transformed phenotype. In order to
characterize Cr(VI) transformed cells and identify the genes
mediating Cr(VI) transformation, we analyzed the gene expression
profiles in Cr(VI) transformed cell lines using microarray analysis.
Three independent cell lines from each group (Cr_large, Cr_small,
untreated control) were randomly chosen and subjected to
microarray analysis using Affymetrix Human Gene 1.0 ST Array
containing 28,869 well-annotated genes. Parental BEAS-2B cells
were also included in this study.
First, we explored the microarray results by comparing gene
expression profiles among Cr_large, Cr_small and untreated
control groups. As shown in Figure 4A, a total of 1289 genes in
the Cr_small group and 1216 genes in the Cr_large group
displayed a greater than 1.5-fold difference as compared with the
control group. When the cut-off threshold was increased to a
5.0-fold difference, the numbers decreased to 40 and 47
respectively (Figure 4B). Interestingly, when the Cr_small
group and the Cr_large group were compared, only 21 genes
whose expression changed more than 1.5-fold showed a
statistically significant difference between the two groups
(p,0.05, alpha level only), but none of these genes exhibited
more than a 2.0-fold change, suggesting that cells from the
Cr_large and the Cr_small group shared a very similar gene
expression pattern. Principal Components Analysis (PCA) of the
microarray data revealed a clear separation among samples from
the control group and those from both Cr(VI) transformed
groups (Figure 4C, square vs triangle), but not between the
Cr_large and the Cr_small groups (Figure 4B, brown vs blue
triangles). The size of the small colonies derived from the Cr(VI)
treated cells were specifically selected to match the size of the
control colonies, indicating that it is the Cr(VI) treatment and
not the colony size that contributed to the observed differences
in gene expression.
Identification of differentially expressed genes in Cr(VI)
transformed cells
Since the gene expression pattern from the Cr_large group and
the Cr-small group were quite similar, a combined gene list from
Figure 2. Chronic exposure of Cr(VI) promotes the anchorage-
independent growth of BEAS-2B cells. BEAS-2B cells were exposed
to 0.25 or 0.5 mM Cr(VI) for 1 month, and assessed for anchorage-
independent growth using a soft agar assay. 3 weeks later, cell colonies
were stained with INT/BCIP and photographed. (A) Representative
plates in soft agar assay were shown. (B) Numbers of colonies per well
were counted and presented as the mean 6 SD (n=4).
doi:10.1371/journal.pone.0017982.g002
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untreated control. After elimination of the probe sets that
represented unannotated genes, there were a total of 45 genes
that changed more than 5-fold in 1 out of 2 groups in the Cr(VI)
transformed cells compared with the control group, including 23
down-regulated and 22 up-regulated genes. The gene names and
fold change of these two groups are listed in Table 1.
Among genes up-regulated in chromate transformed cells, there
were two major sub-groups. The first group was related to female
reproduction, including 5 pregnancy specific beta-1-glycoproteins
Figure 3. Distinct cell morphology of Cr(VI) transformed cells and tumor formation in nude mice. (A) Representative image of normal
BEAS-2B cells (Beas-2B), control cells derived from spontaneously derived colonies of untreated cells (control), Cr(VI) transformed cells derived from
large colonies (Cr_large) or small colonies (Cr_small) of 0.5 mM Cr(VI) treated cells grown in low density. (B) Normal BEAS-2B cells, control and Cr(VI)
transformed cells were seeded at 2500 cells/well in 96-well plates. Cell numbers were measured by MTS assay at the indicated time point. Results
were represented as mean 6 SD (n=6). (C) Representative image of tumor formation in nude mice after subcutaneously injection of control cells
(control-2) and Cr-transformed cells derived from large colonies (Cr_L2) or small colonies (Cr_S2, S3).
doi:10.1371/journal.pone.0017982.g003
Figure 4. Gene expression profiles of control and Cr(VI) transformed cells. (A) Venn diagram showing the numbers of entities with more
than 1.5-fold changed expression in pairwise comparison of Cr_large, Cr_small and control group. Numbers inside each compartment represent the
number of entities. (B) The number of entities with more than 1.5-, 2-, and 5-fold changed expression level in pairwise comparison. (C) Principal
Components Analysis revealed distinct separation between control cells and Cr(VI) transformed cells. Red square: control group; brown triangle:
Cr_small group; blue triangle: Cr_large group.
doi:10.1371/journal.pone.0017982.g004
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8022692 DSC3 desmocollin 3 36.99 40.20
8069676 ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 16.80 28.63
8174513 CHRDL1 chordin-like 1 14.05 18.21
8037272 PSG5 pregnancy specific beta-1-glycoprotein 5 10.33 9.21
8037267 PSG2 pregnancy specific beta-1-glycoprotein 2 10.32 8.06
8072626 TIMP3 TIMP metallopeptidase inhibitor 3 9.43 7.55
8037251 PSG7/8/4 pregnancy specific beta-1-glycoprotein 7/8/4 9.41 8.41
7961142 OLR1 oxidized low density lipoprotein (lectin-like) receptor 1 9.29 4.89
8169949 RP6-213H19.1 serine/threonine protein kinase MST4 8.94 6.11
8022711 DSC2 desmocollin 2 8.00 7.03
7912520 NPPB natriuretic peptide precursor B 6.80 4.71
8037231 PSG3 pregnancy specific beta-1-glycoprotein 3 6.73 6.15
8112274 ELOVL7 ELOVL family member 7 6.04 4.72
8059279 EPHA4 EPH receptor A4 5.86 5.52
8168589 ZNF711 zinc finger protein 711 5.67 3.97
8129880 PERP PERP, TP53 apoptosis effector 5.61 3.11
8015268 KRT34 keratin 34 5.36 3.66
8152506 SAMD12 sterile alpha motif domain containing 12 4.79 5.96
8063536 TFAP2C transcription factor AP-2 gamma 4.74 5.10
8058091 SATB2 SATB homeobox 2 4.68 5.59
8069689 ADAMTS5 ADAM metallopeptidase with thrombospondin type 1 motif, 5 4.52 5.45
8037240 PSG1 pregnancy specific beta-1-glycoprotein 1 3.65 5.37
7997642 CRISPLD2 cysteine-rich secretory protein LCCL domain containing 2 -5.02 -5.93
8176578 USP9Y ubiquitin specific peptidase 9, Y-linked 25.07 25.50
8113073 ARRDC3 arrestin domain containing 3 25.23 24.66
8098204 CPE carboxypeptidase E 25.28 24.34
8089145 ABI3BP ABI gene family, member 3 (NESH) binding protein 25.44 24.74
8029779 IGFL1 IGF-like family member 1 25.47 26.36
8170648 BGN biglycan 25.58 25.76
8067233 PMEPA1 prostate transmembrane protein, androgen induced 1 25.98 25.70
8157524 TLR4 toll-like receptor 4 26.62 28.58
8059580 DNER delta/notch-like EGF repeat containing 26.76 26.34
8121277 AIM1 absent in melanoma 1 26.91 26.69
7902565 LPHN2 latrophilin 2 27.64 23.69
8051583 CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 27.87 23.65
8176384 ZFY zinc finger protein, Y-linked 27.95 28.34
8177222 CD24 CD24 molecule 211.36 29.99
8097628 HHIP hedgehog interacting protein 211.53 212.45
7981986 SNRPN small nuclear ribonucleoprotein polypeptide N 211.73 211.80
8104746 NPR3 natriuretic peptide receptor C/guanylate cyclase C 212.13 213.03
8122150 EYA4 eyes absent homolog 4 (Drosophila) 212.48 212.72
8176719 EIF1AY eukaryotic translation initiation factor 1A, Y-linked 214.55 215.00
8057620 COL5A2 collagen, type V, alpha 2 219.76 218.94
8176624 DDX3Y DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked 225.71 226.58
8176375 RPS4Y1 ribosomal protein S4, Y-linked 1 232.64 232.95
doi:10.1371/journal.pone.0017982.t001
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19. The second group contained three genes (DSC2, DSC3 and
Perp) required for the assembly of the desmosome complex, a cell-
to-cell junction important for maintaining the structural integrity
of the epithelia.
In contrast to the up-regulated genes, the down-regulated gene
exhibited more diversification in functional categories. Most of
down-regulated genes encoded proteins that were either localized
in the plasma membrane or in the extracellular space. For
example, a major sub-group of the down-regulated genes encoded
proteins associated with a cell surface receptor that mediated cell
signaling, including CD24, DDX3Y, BGN, CPE, DNER, HHIP,
LPHN 2, and TLR4. Interestingly, among the most significantly
down-regulated genes, RPS4Y1, DDX3Y, EIF1AY, ZFY and
USP9Y, were located on the Y chromosome. The five PSG genes
increased in Cr(VI) transformed cells were also localized in a
cluster on chromosome 19. It is not clear whether these changes
were gene-specific or loci-specific. Cr(VI) exposure has been
shown to induce chromosome instability, including both numerical
and structural aberrations, which might cause similar expression
changes in multiple genes clustered in a chromosomal region. It is
worth noting that all six Cr(VI) transformed cell lines exhibited
similar changes in these two sub-groups of genes. Further analysis
of chromosome damage and aberration as well as epigenetic
mapping of these Cr(VI) transformed cells will help us to
understand the underlying mechanism for these gene expression
changes.
Real time PCR Validation of gene expression
To validate the results obtained from our microarray study,
quantitative real-time PCR was performed on a subset of 4 genes
exhibiting at least a 5-fold change in gene expression. Three up-
regulated genes (KRT34, DSC3, PSG2) and 1 down-regulated
gene (RSP4Y) were chosen based on their levels of expression in
the microarray study. Differential expression of these genes in
either Cr_large or Cr_small samples was validated using
quantitative real-time PCR. As shown in Figure 5, the up- or
down-regulated patterns for 4 genes obtained from real-time PCR
were similar to those in the microarray study.
Functional annotation and pathway analysis of
differentially expressed genes
To assess the biological relevance of the differentially expressed
genes, we performed the Gene Ontology (GO) annotation and
pathway analysis using the DAVID functional annotation software
[17]. The combined gene list from two Cr(VI) transformed groups
exhibiting more than a 2-fold change in gene expression were used
to identify the functional categories that were significantly over-
represented (p,0.05) in Cr(VI) transformed cells. There were a
total of 409 genes, including 142 up-regulated and 267 down-
regulated genes (Table S1). GO term and KEGG pathways with
significant over-representation were listed in Table 2 (up-
regulated genes) and Table 3 (down-regulated genes). Among
142 up-regulated genes, the largest group with respect to both
degree of significance (p,0.01) and number of genes was
extracellular region (n=22) in Cellular component, followed by
cell motion (n=10) in Biological process. The major pathways
associated with up-regulated genes are p53 pathways (n=3) and
PPAR pathways (n=3). Among 267 down-regulated genes, the
largest group with respect to both degree of significance (p,0.001)
and number of genes was extracellular region (n=22) in Cellular
component, followed by cell motion (n=10) in Biological process.
The major pathways associated with down-regulated genes were
Focal adhesion (n=12) and ECM-receptor interaction (n=7). The
following is a summary of genes changed in several major
functional categories.
Changes in genes associated with cell junction. A major
group of genes altered in Cr(VI) transformed cells were genes
related to cell junction, a type of specialized structure mediating
the contact between cells or between cells and extracellular matrix.
In epithelial cells, there are four major types of cell-cell junctions:
tight junction, gap junction, adherens junction and desmosomes.
The major components of the desmosome complex, DSC2,
DSC3, and Perp, are increased approximately 8-, 40- and 5- fold,
respectively, in Cr(VI) transformed cells. In addition, CDH6, a
type II classical cadherin involved in adherens junction, and
CLDN1, the major protein for tight junction, are also up-regulated
4- and 2-fold, respectively, in Cr(VI) transformed cells. L1CAM,
the L1 cell adhesion molecule, increased 4.7-fold in Cr(VI)
transformed cells. Thus, genes associated with cell junction were
up-regulated in Cr(VI) transformed cells.
Changes in genes associated with cell to extracellular
matrix adhesion. In contrast to up-regulation of genes related
to cell-to-cell contact, many genes involved in focal adhesion, a
major type of cell junction mediating cell and extracellular matrix
interaction, were decreased in Cr(VI) transformed cells. Integrins,
the key component of focal adhesion, are transmembrane
receptors that recognize and bind to most extracellular matrix
proteins, such as collagens, fibronectin, and laminins [18]. Each
integrin molecule is a heterodimer formed from 9 beta and 25
alpha subunits. Cr(VI) transformed cells exhibited decreased
integrin alpha 5 (ITGA5), beta 3 (ITGB3) and beta-like 1
subunits (ITGBL1), but increased alpha 4 subunit (ITGA4).
Similarly, the major component of the extracellular matrix, the
ligands of the integrin receptor, were also decreased in Cr(VI)
transformed cells: COL4A1, COL5A1, COL5A2, LAMB1 and
LAMC2. Moreover, Fibulin-1 (FBLN1), an extracellular matrix
protein often associated with fibronectin, which was able to inhibit
the motility of a variety of cell types [19], decreased 3.6-fold in
transformed cells. Fibrillin-1, a large extracellular matrix
glycoprotein that sequestered TGFb via an interaction with
latent TGFb binding protein [20], was also down-regulated in
Cr(VI) transformed cells.
Additional changes in genes associated with extracellular
matrix. ADAM metallopeptidase with thrombospondin type 1
molecules, ADAMTS-1 and ADAMTS-5, were up regulated 28-
and 5.4-fold respectively in Cr(VI) transformed cells. It was
reported that over-expression of ADAMTS-1 promoted
pulmonary metastasis of TA3 mammary carcinoma and Lewis
lung carcinoma cells [21], and forced expression of ADAMTS-5 in
glioma cell lines stimulated cell invasion [22]. In addition, matrix
metalloproteinase-2 (MMP-2), an enzyme which degraded type IV
collagen, was decreased in Cr(VI) transformed cells.
Simultaneously, its inhibitor, TIMP-3, was up-regulated more
than 9-fold in the transformed cells.
Changes in genes associated with cell proliferation and
growth. Despite the slightly faster growth rates observed in
transformed cells, the expression of cell cycle related genes were
quite similar in control and Cr(VI) transformed cells, with the
exception of cyclin D1, which was increased about 2-fold in Cr(VI)
transformed cells. Interestingly, dysregulation of cyclin D1 was
found in 11 out of 16 (69%) chromium-induced lung SCC but only
3 out of 26 (12%) non-exposed lung SCC [23], indicating a specific
connection between cyclin D1 overexpression and the lung cancer
induced by chromate exposure. Thus, our finding of increased
cyclin D1 in Cr(VI) transformed cells was consistent with the
finding in vivo, supporting a crucial role of cyclin D1 in the
development of chromate induced lung cancer.
Gene Expression in Chromate Transformed Cells
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genes that regulated cell proliferation were also altered in
expression. TGFb signaling [24] and hedgehog signaling [25]
are important pathways involved in regulating cell growth. We
observed that there was decreased expression of TGFb2 and
TGFbR2 (2.4- and 3.5-fold respectively) in Cr(VI) transformed
cells, suggesting that the loss of a cell response to TGFb induced
growth inhibition might be an early step of cellular transformation
and tumorigenesis. Moreover, HHIP, a gene that antagonizes
hedgehog signaling pathways, was decreased about 12-fold in
Cr(VI) transformed cells.
Changes in genes associated with cell apoptosis. There
are two major pathways controlling cell apoptosis. The extrinsic
pathway involves the interaction of a death receptor including Fas
and TNF receptor superfamily members and ligands, and the
intrinsic pathway involves the mitochondria that operate in both
p53-dependent and independent manner [26][27]. Although the
molecules involved in each pathway were quite different, both
pathways lead to caspase activation and apoptosis. Several direct
targets of p53 were increased in Cr(VI) transformed cells,
including CYFIP2, Perp, and RNF144B, which were known to
mediate p53-dependent apoptosis. MRPS30, a mitochondrial
ribosomal protein associated with programmed cell death, was also
up-regulated in transformed cells. In contrast to up-regulated
genes related to intrinsic apoptosis, genes associated with extrinsic
apoptosis pathways were slightly down-regulated in transformed
cells. For example, NUAK2, a gene induced by FasL or TNF-
alpha [28], was down-regulted 2-fold. It was previously reported
that NUAK2 protects cells from FasL mediated cell apoptosis [29].
SEMA3A and RHOB, are also associated with the TNF and Fas
pathways, and they decreased 4- and 3.1-fold, respectively. Within
the caspase family member, only caspase 4 was found to be
increased in Cr(VI) transformed cells.
Identification of genes commonly expressed in both
Cr(VI) treated and control cells
Both Cr(VI)-transformed and control cells were derived from
colonies that grew in soft agar. These cells underwent a change in
growth that may have caused an alteration in gene expression. We
next compared the gene expression profiles from cells derived from
the soft agar colonies to their parental BEAS-2B cells. As shown in
Figure 6A, there was a total of 851 genes changed more than 2-
Figure 5. Validation of microarray results by quantitative RT-PCR. Total RNA was extracted from two cell lines each of control, Cr_small, and
Cr_large group, as well as parental BEAS-2B cells. Expression levels of KRT34, DSC3, PSG2 and RSP4Y were analyzed by quantitative RT-PCR. Relative
gene expression level, normalized to 18s rRNA expression, was presented as fold change to the level expressed in Beas-2B cells. Data are mean 6 SD
(n=3). The expression value of each gene determined from the microarray data was listed below the corresponding PCR results. The color bar related
color code to the expression value determined after quantile normalization and baseline transformation to the median levels of all samples.
doi:10.1371/journal.pone.0017982.g005
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including 325 genes (38%) from the control group, 572 genes
(67%) from the Cr_small group, and 528 genes (62%) from the
Cr_large group. Similarly, within the 92 genes that changed more
than 5-fold, only 13 genes (13%) are from the control group,
compared to 42 (46%) and 37 (40%) genes in the Cr_small and the
Cr_large groups, respectively (Figure 6B). Therefore, the
differences between the Cr(VI) transformed cells and the control
cells that grew in soft agar were more striking as compared to any
differences caused by growth in soft agar.
Similar results can be seen by a hierarchical clustering analysis
of 851 genes (Figure 6C), in which the samples were sorted based
on the similarity of gene expression. The gene expression profiles
of Cr(VI) treated cells were clearly separated from those in the
control group as well as in parental BEAS-2B cells, however, no
obvious separation can be seen among the six Cr(VI) transformed
cell lines that were derived from colonies with different sizes. In
contrast, control cells shared similar expression profiles with
parental BEAS-2B cells and were clustered in the same group. It is
of interest that the heat maps of gene expression were remarkably
similar in six independently derived cell lines following Cr(VI)
exposure. Additionally heat maps of control cell lines derived from
spontaneously arose clones were also remarkably similar to each
other, yet very different from those derived from Cr(VI) exposed
cells.
It is worth noting that there were 108 entities shared by three
groups as shown by the Venn diagram (Fig. 6A). 91 out of 108
entities represented well-annotated genes with similar changes in
gene expression between control and Cr(VI) treated cells, which
are likely the outcome of anchorage-independent growth.
Functional annotation of these genes revealed an up-regulation
of genes involved in the p53 signaling pathway and angiogenesis,
as well as a down-regulation of genes associated with cell adhesion
and cell growth inhibition. The complete list of 91 genes including
41 up-regulated and 50 down-regulated genes as well as the
functional annotation can be found in Tables S2 and S3.
Loss of TGF-b1 responsiveness in Cr(VI) transformed cells
TGFb family members regulate a wide range of biological
processes including cell proliferation, migration, differentiation,
apoptosis, and extracellular matrix deposition [24]. Previous
reports showed that TGF-b1 can cause growth inhibition in
normal human bronchial epithelial (NHBE) [30] and BEAS-2B
cells [31], but not in human lung carcinoma A549 cells [30] as well
as BEAS-2B cells overexpressing mutant p53 [31]. Resistance to
TGFb mediated growth inhibition in human lung cancer may
occur through the loss of type II receptor (TGFbR2) expression.
For example, it was reported that 77% NSCLC exhibited a
reduced level of TGFbR2 [32]. Forced expression of TGFbR2 in
lung cancer cells showed reduced colony formation in a soft agar
assay as well as reduced tumorigenicity when injected into athymic
nude mice [32]. Since the levels of TGFbR2 were down-regulated
in Cr(VI) transformed cells (Fig. 7A), we tested whether these cells
retained their ability to response to TGF-b1 induced growth
inhibition. Control and Cr(VI) transformed cells as well as BEAS-
2B cells were exposed to 10 ng/ml of recombinant human TGF-
b1 for 24 hours. DNA synthesis were measured by [
3H]thymidine
incorporation. Consistent with previous reports, thymidine
Table 2. Functional Annotation and pathway analysis of genes increased more than 2-fold in Cr(VI) transformed cells.
Category GO Term Number of genes P Value
Biological Process female pregnancy 8 0.0007
cell migration 8 0.0020
cell motion 12 0.0035
reproduction 14 0.0102
cell adhesion 11 0.0145
cell differentiation 23 0.0158
cell death 15 0.0172
cell surface receptor linked signal transduction 20 0.0261
blood circulation 5 0.0322
fatty acid metabolic process 5 0.0391
neurogenesis 9 0.0398
folic acid transport 2 0.0443
spermatid development 3 0.0474
Molecular Function sugar binding 5 0.0279
folic acid transporter activity 2 0.0290
vitamin binding 4 0.0412
Cellular Component desmosome 3 0.0066
extracellular region 22 0.0099
plasma membrane 33 0.0279
cell junction 8 0.0408
axon part 3 0.0437
KEGG Pathway p53 signaling pathway 3 0.0910
PPAR signaling pathway 3 0.0933
doi:10.1371/journal.pone.0017982.t002
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and 40% respectively in the presence of TGF-b1. However, Cr(VI)
transformed cells from both Cr_large and Cr_small colony groups
exhibited an increased DNA synthesis after exposing to TGF-b1
(Fig. 7B), suggesting that these transformed cells were able to
escape from TGFb1 induced growth arrest. These results further
support that the loss of a cell response to TGFb induced growth
inhibition is acquired during cellular transformation and
tumorigenesis.
Discussion
Cr(VI) is a well established carcinogen that induced respiratory
cancer and several other types of human cancer [2–3]. However,
the molecular mechanism underlying Cr(VI) induced lung cancer
and the down-stream genes that mediated Cr(VI) carcinogenicity
are not complete understood. In the present study, we showed that
chronic exposure of immortalized normal human bronchial
epithelial BEAS-2B cells to low doses of Cr(VI) significantly
enhanced their ability to grow in an anchorage-independent
manner as assessed by increased number and size of soft agar
colonies. In addition, the cell lines derived from the Cr(VI) exposed
colonies exhibited striking changes in cell morphology and were
able to form tumors when injected into nude mice, indicating that
Cr(VI) was capable of inducing malignant transformation in BEAS-
2B cells. Moreover, gene expression analysis revealed a change in
expression profile in Cr(VI) transformed cells that may facilitate cell
growth and migration. Interestingly, the gene expression profile of
six Cr(VI) transformed cell lines were remarkably similar to each
other, yet very different from those of the control cell lines,
Table 3. Functional Annotation and pathway analysis of genes decreased more than 2-fold in Cr(VI) transformed cells.
Category GO Term Number of genes P Value
Biological Process wound healing 12 0.00002
angiogenesis 8 0.00239
cell motion 14 0.00600
blood circulation 8 0.00828
cell differentiation 32 0.00970
regulation of cell growth 8 0.01029
regulation of cell size 8 0.01397
response to drug 8 0.01766
cell adhesion 16 0.02637
heterophilic cell adhesion 3 0.02969
regulation of cell communication 21 0.03085
transforming growth factor beta receptor signaling pathway 4 0.03776
response to stress 30 0.03898
respiratory system development 5 0.04454
chromatin organization 10 0.04470
epidermal growth factor receptor signaling pathway 3 0.04632
elevation of cytosolic calcium ion concentration 5 0.04710
Molecular Function carbohydrate binding 15 0.00014
calcium ion binding 25 0.00044
metallopeptidase activity 10 0.00047
metal ion binding 69 0.00480
actin binding 10 0.02074
integrin binding 4 0.03687
heparin binding 5 0.03940
GTPase binding 5 0.04686
Cellular Component extracellular matrix 13 0.00076
plasma membrane 64 0.00108
cytoplasm 106 0.00259
extracellular space 18 0.00284
chromatin 7 0.03015
collagen type V 2 0.03467
integrin complex 3 0.04491
lamellipodium 4 0.04870
KEGG pathway Focal adhesion 12 0.00041
EMC-receptor interaction 7 0.00246
doi:10.1371/journal.pone.0017982.t003
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of chronic Cr(VI) exposure.
Two recent studies have reported the effect of chronic Cr(VI)
exposure on BEAS-2B cells. Rodrigues et al. reported the
establishment of Cr(VI) transformed cells by ring-cloning BEAS-
2B cell after chronic exposure of cells to 1 mM Cr(VI) [33]. These
transformed cells exhibited an aneuploid phenotype, up-regulation
of genes associated with malignant transformation and DNA
repair, as well as the ability to form tumors in nude mice [33]. Our
present study confirmed their finding that chronic exposure to
Cr(VI) could result in malignant transformation of BEAS-2B cells.
However, we were not able to detect any changes in genes
associated with DNA repair as reported by Rodrigues et al. The
difference is likely due to the strategies used to establish
transformed cell lines. In Rodrigues’ study, cells were continuously
exposed to Cr(VI) after the transformed clones were derived [33].
In our study, Cr(VI) exposure was terminated after 30 days. Cells
were then allowed to form colonies in soft agar and subsequently
expanded in monolayer in the absence of Cr(VI). Therefore, cells
in their study were constantly exposed to Cr(VI) that activated a
response to DNA damage and expressed genes related to DNA
repair. Clearly, this was not the case in our study. A lack of
continuous exposure to Cr(VI) may also explain why there were
very few changes in genes related to oxidative stress in our
transformed cells.
Costa et al reported that chronic exposure of BEAS-2B cells to
sub-cytotoxic Cr(VI) resulted in dramatic changes in cell
morphology and growth patterns [34], that was in agreement
with our observation. Cr(VI) treated and transformed cells were
more sensitive to trypsinization, suggesting extracellular matrix
adhesion is a major target of Cr(VI). The phenotypic change of
transformed cells was further supported by alteration in expression
of genes during Cr(VI) induced cell transformation. The genes
associated with cell to matrix adhesion were significantly down-
regulated in Cr(VI) transformed cells, including many genes
involved in focal adhesion. Decreased gene expression of integrin
receptors, ligands, and other matrix components could result in a
poor connection between cells and the substratum, that in turn
could have contributed to a transformation phenotype and further
facilitated cell migration and invasion.
Figure 6. Gene expression profiles of control, Cr(VI) transformed and parental BEAS-2B cells. (A) Venn diagram showing the numbers of
entities with more than 2-fold changed expression in pairwise comparison of Cr_large, Cr_small, control group and parental BEAS-2B cells. Numbers
inside each compartment represent the number of entities. (B) The number of genes with more than 1.5-, 2-, and 5-fold changed expression level in
pairwise comparison. (C) Hierarchical cluster analysis of genes with more than 2-fold changed expression in one out of three groups (control,
Cr_small, Cr_large) compared to parental BEAS-2B cells. The color bar related color code to the expression value determined after quantile
normalization and baseline transformation to the median levels of all samples.
doi:10.1371/journal.pone.0017982.g006
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increased in Cr(VI) transformed cells. Genes belonging to this
category were normally down-regulated during tumorigenesis to
free tumor cells from the surrounding cell contacts and facilitate
tumor invasion and metastasis. However, dysregulation of cell
junction genes were found in a number of human cancers, and
were required for tumor cell motility and invasion. For example,
up-regulation of CHD6 has been observed in several types of
human cancer, suggesting a possible role in metastasis and
invasion [35]. L1CAM was reported to be involved in the
advanced stages of tumor progression, and over expression of
L1CAM in normal and tumor cells increased cell motility and
metastasis [36]. Interestingly, both CHD6 and L1CAM were
increased more than 4-fold in Cr(VI) transformed cells, suggesting
a possible role of cell junction related genes in Cr(VI) induced cell
transformation.
It is worth noting that our study demonstrated a dramatic
increase in genes associated with desmosome complex in Cr(VI)
transformed cells. Desmosome is a intracellular junction mediating
the interaction between adjacent epithelials. Desmocollins (DSC1,
DSC2 and DSC3) are members of the cadherin family, which
form the transmembrane core of the desmosome through
heterotypic interaction with another member of the same family,
desmogleins (DSG) [37][38]. Depletion of DSC3 in mice resulted
in embryonic lethality before implantation [39], while conditional
depletion of DSC3 in mouse epidermis led to epidermal blistering
[40]. Perp was originally known as an apoptosis-associated target
of p53. Recent work on Perp null mice indicate that Perp is crucial
for desmosome formation as the Perp deficient mice died post-
natally with dramatic blistering similar to DSC1 null mice [41].
Recently, DSC2 and DSC3 were found increased in human lung
cancer, especially in lung squamous cell carcinoma [42]. DSC3
was considered as a marker for squamous carcinoma due to its
high levels in almost all lung squamous carcinoma [43].
Interestingly, the majority of lung cancers in chromium workers
were squamous cell carcinoma. Our finding that DSC3 increased
more than 40-fold in Cr(VI) transformed cells was consistent with
its high level in tumor cells. Two other components of desmosome,
DCS2 and Perp, were also up-regulated in Cr(VI) transformed
cells. It is possible that these desmosome genes were direct targets
of chronic Cr(VI) exposure, and their up-regulation by Cr(VI) may
contribute to its carcinogenicity. In addition, genes related to cell
cycle control as well as cell proliferation were also changed. The
level of cyclin D1, an important cyclin expressed in early G1 phase
and required for cell cycle progression, was increased in Cr(VI)
transformed cells. Dysregulation of cyclin D1 was frequently found
in the early stage of tumorigenesis in many different cancers, and
has been reported at high levels in chromate induced lung cancers.
TGFb is an important negative regulator of lung epithelial cells,
and loss of TGFb signaling is an early event that contributes to cell
growth. Cr(VI) transformed cells exhibited significantly reduced
levels of TGFb2 and TGFbR2, and were able to escape from
TGFb induced growth inhibition. These results suggested that
Cr(VI) may have promoted tumor cell growth by stimulating
proliferation associated genes and inhibiting anti-proliferation
genes.
In summary, our studies analyzed gene expression profiles in
transformed cells lines expanded from a single colony in soft agar
after chronic exposure to low doses of Cr(VI). We have identified
many novel changes in gene expression that were different from
the immediate response genes identified from previous studies
using acute exposure of Cr(VI). These genes may be involved in
Cr(VI) induced malignant transformation. Thus, further analysis
of these genes in vivo and dissecting the mechanism of Cr(VI)
induced expression alterations will provide a better understanding
of the mechanism underlying chromium carcinogenicity.
Materials and Methods
Cell Culture
Human normal bronchial epithelial BEAS-2B cells [44] were
cultured in DMEM (Invitrogen) supplemented with 10% FBS and
100 U/ml penicillin and 100 mg/ml streptomycin (Invitrogen).
The cells were cultured at 37uC in an incubator with a humidified
Figure 7. Reduced level of TGF-b type II receptor and resistance to TGF-b1 induced growth inhibition in Cr(VI) transformed cells. (A)
Total RNA was extracted BEAS-2B, control, and Cr(VI) transformed cells. Expression levels of type II TGF-b receptor were analyzed by quantitative RT-
PCR. Relative gene expression level, normalized to 18s rRNA expression, was presented as fold change to the level expressed in Beas-2B cells. (B)
Normal BEAS-2B cells (Beas-2B), control cells (control), and Cr(VI) transformed cells (Cr_large, Cr_small) were seeded at 5000 cells/well in 96-well
plates. Cells were then either left untreated or treated with 10 ng/ml TGF-b for 24 hr. Cell proliferation was measured by [
3H]thymidine incorporation.
Results were represented as mean 6 SD (n=3).
doi:10.1371/journal.pone.0017982.g007
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treated with 0.25 or 0.5 mM potassium chromate (K2CrO4, J. T.
Baker Chemical Co.) for 1 month. The medium was changed
every other day, and cells were split in the presence of Cr(VI) every
3 days.
Colony survival assay
BEAS-2B cells were treated with various doses of Cr(VI) (0.25,
0.5, 1.0, 2.0, and 4.0 mM) for 24 hours. Control and Cr(VI) treated
cells were plated at 500 cells/dish in 100-mm cell culture dishes,
and cultured for two weeks. Cells were stained with Giemsa
solution, and the number of colonies was counted and presented as
mean 6 SD (n=3).
Cell proliferation assay
Normal BEAS-2B cells, control cells derived from spontane-
ously formed colonies of untreated cells, and Cr(VI) transformed
cells derived from large colonies (Cr_large) or small colonies
(Cr_small) were seeded at 2500 cells/well in 96-well plates. Viable
cell number was determined using the MTS CellTiter 96 aqueous




Cells were seeded at density of 5610
4 cells/well in 24-well plate.
On the following day, cells were treated with 10 ng/ml
recombinant human TGF-b1 (R&D System) for 24 hr. Cells were
then pulse labeled with 0.5 mCi of [
3H]thymidine for 2 hr. The
cells were washed twice with ice cold PBS, followed by precipitated
with ice-cold 5% TCA twice, each with 10 minutes. The cells were
then extracted with 0.5 ml of 0.5 M NaOH for 2 hours at room
temperature, and neutralized with 0.25ml of 1N HCl. The cell
lysate was transferred to scintillation vials with 5 ml of scintillation
fluid, and the radioactivity was assessed using a Scintillation
Counter.
In vivo tumorigenesis
Six-week old female athymic nude mice (NCI, Frederick) were
injected subcutaneously at the left or the right flank with control
cells and Cr transformed cells (5610
6 cells/0.1 ml/injection).
Each cell line was injected into 3 mice. Six months later, the mice
were photographed and sacrificed. Tumors and other tissues were
collected for further analysis.
Soft-agar assays
Control and Cr(VI) treated cells were plated at 5000 cells/well
in 6-well plates with culture medium containing 0.35% low-
melting-point agarose over a 0.5% agarose base layer and cultured
at 37uC incubator with 5% CO2 for 3 weeks. The colonies were
stained with INT/BCIP (Roche) and photographed.
Microarray hybridization and data analysis
Total RNA from each cell line was extracted using Trizol
(Invitrogen) according to the manufacturer’s protocol. cRNA
probes were synthesized and labeled using GeneChip Whole
Transcript cDNA Synthesis and Amplification Kit and Terminal
Labeling Kit (Affymetrix), and were subjected to hybridization
with GeneChip Human Gene 1.0 ST Array (Affymetrix) that
contains 28,869 well annotated genes. Hybridization and scanning
of the arrays was performed using a standard procedure.
Microarray data analysis was performed using GeneSpring v11
(Agilent Technologies). All microarray data is MIAME compliant
and the raw data has been deposited in NCBIs Gene Expression
Omnibus (GEO), and assigned Series accession number
GSE24025. The expression value of each probe set was
determined after quantile normalization using RMA16 algorithm
and baseline transformation to the median levels of control
samples. Differentially expressed genes were identified using an
unpaired T test (p,0.05). Principal component analysis (PCA) was
used to visualize the gene expression pattern of all samples.
Hierarchical cluster analysis using Euclidean distance was
performed to cluster genes and samples for heatmap. Functional
annotation was analyzed with the Gene Ontology (GO) classifi-
cation system using DAVID software (http://david.abcc.ncifcrf.
gov/home.jsp).
Real-time quantitative PCR
Total RNA was extracted from each cell line using TRIzol
Reagent (Invitrogen), and converted to single stranded cDNA
using Superscrip III (Invitrogen). Quantitative real-time PCR
analysis was performed using SYBR green PCR system (Applied
Biosystems) on ABI prism 7900HT system (Applied Biosystems).
All PCR reactions were performed in triplicate. Relative gene
expression level, normalized to 18s rRNA expression, was
calculated by 2
2DDCt. The results were presented as fold change
to the level expressed in BEAS-2B cells.
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